Loading...
Holdco Nuvo Group D.G Ltd. Warrants
NUVOW•NASDAQ
Healthcare
Medical - Devices
$0.005
$0.00(6.00%)

Over the last four quarters, Holdco Nuvo Group D.G Ltd. Warrants achieved steady financial progress, growing revenue from $25.00 in Q1 2023 to $0.00 in Q4 2023. Gross profit stayed firm with margins at N/A in Q4 2023 versus -104% in Q1 2023. Operating income totaled -$770320.00 in Q4 2023, maintaining a N/A margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$770320.00. Net income rose to -$100310.00, with EPS at -$0.008. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan